Evidence map›Paper›PMID 21282639›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2011

Grb-2-associated binder 1 (Gab1) regulates postnatal ischemic and VEGF-induced angiogenesis through the protein kinase A-endothelial NOS pathway.

Yao Lu, Yan Xiong, Yingqing Huo, Jingyan Han, Xiao Yang, Rongli Zhang, De-Sheng Zhu, Stefan Klein-Hessling, Jun Li, Xiaoyu Zhang and 7 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 5 countries.

Yao LuLaboratory of Vascular Biology, Institute of Molecular MedicineChinese and Western Medicine, School of Basic Medical Sciences, Tasly Microcirculation Research Center, Peking University, Beijing 100871, China.
Yan Xiong
Yingqing Huo
Jingyan Han
Xiao Yang
Rongli Zhang
De-Sheng Zhu
Stefan Klein-Hessling
Jun Li
Xiaoyu Zhang
Xiaofan Han
Yanli Li
Bin Shen
Yulong He
Masabumi Shibuya
Gen-Sheng Feng
Jincai Luo
Institute of Molecular Medicine · INPeking University · CNModel Animal Research Center · CNInstitute of Genetics and Developmental Biology · CNTokyo Medical and Dental University · JPUniversity of California, San Diego · USUniversity of Würzburg · DE

Funding

Tyrosine Dephosphorylation and Blood Cell DevelopmentR01HL096125 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FENG, GEN-SHENG · 2009 to 2013
$1.9M
NHLBI NIH HHS R01 HL096125NHLBI NIH HHS R01HL096125
6 · The paper itself

Abstract

The intracellular signaling mechanisms underlying postnatal angiogenesis are incompletely understood. Herein we show that Grb-2-associated binder 1 (Gab1) plays a critical role in ischemic and VEGF-induced angiogenesis. Endothelium-specific Gab1 KO (EGKO) mice displayed impaired angiogenesis in the ischemic hindlimb despite normal induction of VEGF expression. Matrigel plugs with VEGF implanted in EGKO mice induced fewer capillaries than those in control mice. The vessels and endothelial cells (ECs) derived from EGKO mice were defective in vascular sprouting and tube formation induced by VEGF. Biochemical analyses revealed a substantial reduction of endothelial NOS (eNOS) activation in Gab1-deficient vessels and ECs following VEGF stimulation. Interestingly, the phosphorylation of Akt, an enzyme known to promote VEGF-induced eNOS activation, was increased in Gab1-deficient vessels and ECs whereas protein kinase A (PKA) activity was significantly decreased. Introduction of an active form of PKA rescued VEGF-induced eNOS activation and tube formation in EGKO ECs. Reexpression of WT or mutant Gab1 molecules in EGKO ECs revealed requirement of Gab1/Shp2 association for the activation of PKA and eNOS. Taken together, these results identify Gab1 as a critical upstream signaling component in VEGF-induced eNOS activation and tube formation, which is dependent on PKA. Of note, this pathway is conserved in primary human ECs for VEGF-induced eNOS activation and tube formation, suggesting considerable potential in treatment of human ischemic diseases.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCollagenCyclic AMP-Dependent Protein KinasesDrug CombinationsEndothelial CellsHindlimbHumansIschemiaLamininMiceMice, KnockoutNeovascularization, PhysiologicNitric Oxide Synthase Type IIIPhosphoproteinsPhosphorylationAdaptor Proteins, Signal TransducingCollagenCyclic AMP-Dependent Protein KinasesDrug CombinationsGab1 protein, mouseLamininmatrigelNitric Oxide Synthase Type IIIPhosphoproteinsProteoglycansProto-Oncogene Proteins c-aktVascular Endothelial Growth Factor A

Identifiers

PMID21282639
PMCPMC3041066
OpenAlexW2086386116

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.